Heartland Session Sneak Peek: Revenue Cycle Management – What Are Your Averages?

Published in Member Communities on September 01, 2021

How does your company “stack up” when it comes to:

  • How “clean” your claims are
  • The number of claims paid after only one submission
  • DSO (Days Sales Outstanding)/Accounts receivable aging
  • Number of claims “lost” by payers/resubmitted
  • Number of claim denials and appeals (denial percentage)?

Are all of those statistics as good as they can be for your company? Are they better than industry averages? Do you handle everything in-house, or do you outsource some or all of those functions? Revenue Cycle Management (RCM) is an integral part of any HME business, and how well it is performed can mean the difference between a thriving business and a failing one. Despite its tremendous importance, there simply isn’t a lot of benchmarking data for our industry when it comes to RCM. Product mix, payer mix, intake, benefit verification, prior authorization, and billing practices, collection efforts, etc. all factor into what your RCM numbers ultimately look like. 

Because of those factors, RCM continues to be a topic that generates a lot of questions and discussions. Some of the most common questions that you should know the answers to are: What is your DSO? How does your A/R Aging look, especially the 90 days plus bucket? What is your denial rate? What tools exist within your billing software? Simply knowing the answers to those questions is not enough, though. You also need to know what you would like the answers to those questions to be, or what you think they should be, and what to do if the actual answers don’t match up with the expectation.

At this year’s Heartland Conference, please join Craig Douglas and Ronda Buhrmester from VGM, along with a panel of your industry peers, as they discuss and answer these questions as well as other best practices and potential solutions to help your business thrive. Learn more and register at www.vgmheartland.com.
 


TAGS

  1. billing & reimbursement
  2. conference
  3. education
  4. heartland
  5. vgm

From Our Experts

What AI and Industry Leaders Predict for HME's Future thumbnail What AI and Industry Leaders Predict for HME's Future Discover why HME growth remains strong despite reimbursement uncertainty, increased audits, staffing challenges, and operational pressures. How CRT Can Help HME Providers Diversify and Grow thumbnail How CRT Can Help HME Providers Diversify and Grow Looking to grow beyond traditional HME? Learn why more providers are turning to complex rehab technology and mobility services. How CRT Can Help HME Providers Diversify and Grow thumbnail How CRT Can Help HME Providers Diversify and Grow Looking to grow beyond traditional HME? Learn why more providers are turning to complex rehab technology and mobility services. What Suppliers Need to Know: CMS Expands Access to Non-Invasive Ventilation for COPD Patients thumbnail What Suppliers Need to Know: CMS Expands Access to Non-Invasive Ventilation for COPD Patients While the new NCD creates additional opportunities for patients to receive medically necessary therapy, it also introduces new responsibilities for durable medical equipment (DME) suppliers. VGM Playbook: Emerging Markets and Business Growth thumbnail VGM Playbook: Emerging Markets and Business Growth Explore emerging healthcare markets, growth opportunities, and expansion strategies in pediatrics, sleep, home access, maternity care, and more. 2026 O&P Woman of the Year Finalists Announced thumbnail 2026 O&P Woman of the Year Finalists Announced Meet the 2026 O&P Woman of the Year finalists, recognized for leadership, innovation, and excellence in the orthotics and prosthetics profession. Why Signature Issues Continue to Trip Up DME Suppliers thumbnail Why Signature Issues Continue to Trip Up DME Suppliers Discover why signature-related documentation issues continue to create claim denials, audit risks, and reimbursement challenges for DME suppliers. The Fortune Is in the Follow-Up thumbnail The Fortune Is in the Follow-Up The fortune is in the follow-up. Not because follow-up is exciting. Most of the time it's not. In fact, it's often the least glamorous part of the job. But that's exactly why it creates so much value. Most people are willing to start something. Fewer people are willing to stick with it until it's finished.